Contract with Customer, Liability, Noncurrent in USD of Spyre Therapeutics, Inc. from Q4 2022 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.
Summary
Spyre Therapeutics, Inc. quarterly Contract with Customer, Liability, Noncurrent history and change rate from Q4 2022 to Q4 2023.
  • Spyre Therapeutics, Inc. Contract with Customer, Liability, Noncurrent for the quarter ending 31 Dec 2023 was $0.000, a 100% decline year-over-year.
Contract with Customer, Liability, Noncurrent, Quarterly (USD)
Contract with Customer, Liability, Noncurrent, YoY Quarterly Change (%)

Spyre Therapeutics, Inc. Quarterly Contract with Customer, Liability, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2023 $0 -$2.18M -100% 31 Dec 2023 10-K/A 18 Nov 2024
Q3 2023 $0 30 Sep 2023 10-Q 09 Nov 2023
Q4 2022 $2.18M 31 Dec 2022 10-K/A 18 Nov 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.